5. Price-fixing faux pas

After a two-year investigation, the U.S. Justice Department has dropped the hammer on two former pharmaceutical executives of Heritage Pharmaceuticals. According to Bloomberg, former President Jason Malek and ex-CEO Jeffrey Glazer have been charged with colluding with other pharma companies to raise the prices on generic drugs. The two are preparing to plead guilty and plan on working with prosecutors examining allegations of widespread collusion across manufacturers. A dozen other companies are being investigated with subpoenas already sent to Teva and Mylan. Batten down the hatches as more charges against drug-makers could spring up.